Please use this identifier to cite or link to this item: http://hdl.handle.net/2080/1623
Full metadata record
DC FieldValueLanguage
dc.contributor.authorParida, P-
dc.contributor.authorMishra, S C-
dc.date.accessioned2012-02-16T15:54:07Z-
dc.date.available2012-02-16T15:54:07Z-
dc.date.issued2012-01-
dc.identifier.citationUGC Sponsored National Workshop on Innovative Experiments in Physics, 9-10 January 2012, Neelashaila Mahabidyalaya Rourkelaen
dc.identifier.urihttp://hdl.handle.net/2080/1623-
dc.descriptionCopyright belongs to proceeding Publisher.en
dc.description.abstractSalicylic acid the main metabolite of aspirin, is an integral part of human and animal metabolism. It was discovered by Arthur Eichengrün, a chemist with the German company Bayer. It is rapidly converted in the body to salicylic acid which is responsible for most of the action as analgesic, anti-inflammatory , Platelet aggregation inhibitor (by inhibiting the production of thromboxane), Anticoagulant. It’s actions are the result of acetylation of certain macromolecules including cycloxygenase. It is one of the oldest analgesic, anti-inflammatory drugs and still widely used. Aspirin is also used long-term, at low doses, to help prevent heart, strokes, and blood clot formation in people at high risk of developing blood clots. It has also been established that low doses of aspirin may be given immediately after a heart attack to reduce the risk of another heart attack or of the death of cardiac tissue.en
dc.format.extent2393873 bytes-
dc.format.mimetypeapplication/pdf-
dc.language.isoen-
dc.subjectCAD Modelingen
dc.subjectNanotechnologyen
dc.subjectRenewable Source of Energyen
dc.titleAspirin Leads Multi Therapeutic Indexen
dc.typeArticleen
Appears in Collections:Conference Papers

Files in This Item:
File Description SizeFormat 
4. ASPIRIN LEADS MULTI THERAPEUTIC INDEX..pdf28.39 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.